The evolution of therapeutic modalities drives the adoption of single-use technologies.

Review of SUT Adoption in Biopharma Manufacturing

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

 Automating the Future of Fill/Finish

Topic

Feliza Mirasol is the science editor for 

Articles

The companies will collaborate to create and test circVec DNA–LNP formulations for use in potential therapeutic applications.

Circio and Certest to Collaborate on LNP Formulations

Located in German, Italy, and Lithuania, the new European facilities  will specialize in drug discovery and R&D services. 

Three New European Facilities Established by BioPharmaSpec for R&D

SEKISUI has used a £15.7 million (US$20.7 million) investment to expand its clinical-grade drug substance manufacturing at its UK site. 

CDMO SEKISUI Expands its CGMP Biopharma Manufacturing Capacity

Financing from OrbiMed, Novo Holdings, Jeito Capital, and others will enable Alentis Therapeutics to advance its pipeline of Claudin-1-targeted ADCs for treating solid tumors.

Alentis Therapeutics to Advance Anti-Claudin-1 ADCs to Treat Solid Tumors on $181.4 Million Financing

Frontier Scientific Solutions has unveiled plans to use a $1.5 billion commitment from a major investor to create a global free trade zone gateway to facilitate the life sciences supply chain using Wilmington International Airport in North Carolina.

Frontier Scientific Solutions Plans a Global Free Trade Zone Gateway to Supply Life Sciences Industry on Back of $1.5 Billion Investment

Avantor's newly launched expanded Innovation Center in Bridgewater, NJ, is designed for integrated workflows and features purpose-built collaboration spaces. 

Newly Opened Innovation Center in New Jersey Gives Avantor Advantage in Solving Life Sciences Challenges

Executives at Avantor talk about the future of the biopharmaceutical industry and the anticipated impact that a wave of next-generation biotherapeutics will bring.

Avantor Sees Future of Opportunities with Growing Development of Next-Gen Biotherapeutics

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Videos

Brian Feth and Jonathan Grinstein go behind the headlines to discuss the impact of a Republican administration on Federal Trade Commission actions, tax relief, and Health and Human Services (HHS) leadership; as well as advancements in CAR-T.

Behind the Headlines: What the U.S. Election Results Mean for Industry, In Vivo CAR-T Applications, and more 

Under an ongoing partnership with Merck, known as MSD outside of the United States and Canada, Ginkgo Bioworks has achieved the first milestone in a project aimed at improving biologics production.

Merck and Ginkgo Bioworks’ Collaboration to Improve Biologics Manufacturing Has Reached Its First Milestone

Manufacturers of five autologous or matched allogenic cell therapy products have selected TrakCel's  IT platform, OCELLOS, to orchestrate the administration of these therapies, which are approved or expected to be approved in 2024.

TrakCel’s OCELLOS Platform Selected to Support Treatment Management of Five Upcoming Cell Therapy Products

Aseptic/Sterile Processing

Cleanroom Equipment and Supplies

Clinical Trial Materials

Equipment

Facility Design and Engineering

Fill-Finish

Information Technology

Manufacturing Equipment, Biologics

Manufacturing Equipment, Downstream Processing

Manufacturing Equipment, Fill-Finish

Manufacturing Equipment, Solid Dose Drugs

Manufacturing Equipment, Upstream Processing

Manufacturing Services

Manufacturing Systems, Single-Use

Manufacturing, Biologic Drugs

Manufacturing, Biosimilars and Biobetters

Manufacturing, Cell Culture and Fermentation

Manufacturing, Cell Therapies

Manufacturing, Cell-Line Selection

Manufacturing, Combination Drugs

Manufacturing, Continuous Solid Dosage Processing

Manufacturing, Drug Products

Manufacturing, Expression Systems

Manufacturing, Gene Therapies

Manufacturing, Inhalation Drugs

Manufacturing, Liquid Drug Products

Manufacturing, Lyophilization

Manufacturing, Nucleic Acids

Manufacturing, Parenterals and Injectables

Manufacturing, Process Chromatography

Manufacturing, Recombinant Proteins

Manufacturing, Separation and Purification

Manufacturing, Solid Dosage Drugs

Manufacturing, Specialty Dosage Forms

Manufacturing, Topical Drugs

Manufacturing, Vaccines

Packaging Trends

Packaging, Labeling, and Distribution Systems

PharmTech Products

Process Control, Automation, and PAT

Supply Chain

Technology Transfer

Viral Clearance

Manufacturing